Our Antibiotic Apocalypse correspondent, @GreekDoc, on the latest casualty in the War: Cefiderocol to NDM carbapenemase; pour one out for the Trojan Horse!
With BSAC we are running this very short survey trying to understand how the ideal infection conference looks for you. If you take 3 minutes to complete it, I would be very grateful. It is open to all healthcare professionals.
https://t.co/Fedybkda05
David Mabey officially retires @LSHTM today after a 40+ year career dedicated to improving health & wellbeing globally. It has been a huge privilege for myself & colleagues to have worked with him. Sadness but also pride at the immense impact David has had worldwide. Thank you.
Baltas et al. show that ciprofloxacin prophylaxis during HCT led to fewer infection episodes & reduced exposure to broad spectrum antimicrobials but saw an increased #AMR burden in breakthrough infections:
https://t.co/UqHu1euGNH
@GreekDoc @OUPMedicine @OxfordJournals#JACAMRNews
Meet Dr Ioannis Baltas, 2023 poster prize winner for his work on ‘Post-Vaccination Covid-19: A Case-Control Study and Genomic Analysis of 119 Breakthrough Infections in Partially Vaccinated Individuals’🏆
Could your research win in 2024?
Submit now! 👇
https://t.co/L5e0EgZxZ7
Fantastic collaboration around stability of aciclovir in elastomeric devices for OPAT.First antiviral of the programme! 🇦🇺 @b_fekade @jasonroberts_pk 🇬🇧 @jamiesonce @raseaton66 @BSACandJAC & those not on X https://t.co/nI8u0wt9tQ
Delighted to have been awarded Professor of Practice in the latest promotions @ImperialMed @ImperialInfect @HPRUamr - thank you to everyone in 🇬🇧 and 🌍 (too many to name!) - hugely appreciated @ImperialNHS https://t.co/6yxFyHCYfI
Ahead of Penicillin Allergy Day on 28/9/23 @rpharms has released info on how pharm teams can help raise awareness on the topic - facts, implications around #AMR, patient safety, ways to help. Thank you to all involved - more coming on the 28th! https://t.co/FUk0uxNcTR @UKCPAPIN
Cogliati Dezza et al. identified predictors for CRAB BSI that could be useful to identify patients at highest risk, prompting clinicians to start the most appropriate empirical therapy:
https://t.co/Dpx6PeZnnQ
@OUPMedicine @OxfordJournals#JACAMRNews
Sid Ahmed et al. outline the #AntimicrobialResistance trends in Qatar in 2017-19 with interesting results, particularly for novel antimicrobial agents:
https://t.co/5Z6bHK3qAj
@OUPMedicine @OxfordJournals#JACAMRNews
Curious to know more about the #Netflix model for antimicrobials? The UK’s SMASH study explored views of infection consultants in England on the novel subscription model for #cefiderocol & #ceftazidime-avibactam that started July 2022
https://t.co/MQT9l4RDaO
@GreekDoc#JACAMRNews
Please help junior doctors get fair pay by signing this petition 🙏
Petition: Negotiate with junior doctors on pay and start with offer of inflation-proof pay https://t.co/I6eBt9ffmc
Thanks again to everyone who came out in force for #PayRestoration yesterday.
Today we rest, and remind all our colleagues to vote yes in the industrial action re-ballot.
See you all on the picket lines on Monday! #DoctorsStrike#RestAndVoteYes